References
- Current protpcols in molecular biology v.2 Ausubel, F.M.;R. Brent;R.E. Kingston;D.D. Moore;J.G. Seidman;J.A. Smith;K. Struhl(ed.)
- J. Antimicrob. Chemother. v.34 Farm animal as putative reservoir for vancomycin-resistant enterococcal infection in man Bates, J.;J.Z. Jordens;D.T. Griffith https://doi.org/10.1093/jac/34.4.507
- J. Clin. Microbiol. v.34 Use of in-house studies of molecular epidemiology and full species identification for controlling spread of vancomycin-resistant Entercoccus faecalis isolates Bondnar, R.U.R.;G.A. Noskin;T. Suriano;I. Cooper;B. Reisberg;L. R. Reterson
- Antimicrob. Agents Chemother. v.36 Emergence and nosocomial transmission of ampicillin-resistant enterococci Boyce, J.M.;S.M. Opal;G. Potter-Bynore;R.G. Laforge;M.J. Zervos;G. Furtado;G. Victor;A.A. Meideros https://doi.org/10.1128/AAC.36.5.1032
- Current infectious disease drugs Glycopeptides, polypeptides, teriary amines, furans, nitroimidazoles and other organic compounds Calia, F.M.;V.T. Andriole(ed.)
- Antimocrob. Agents Chemother. v.35 Antimicrobial reistance among enterococci Herman, D.J.;D.N. Gerding https://doi.org/10.1128/AAC.35.1.1
- FEMS Microbiol. Lett. v.125 VanA-mediated high-level glycopeptide resostance in Enterococcus faecium from animal husbandary Klare, I.;H. Heier;H. Claus;R. Reissbrodt;W. Wittw https://doi.org/10.1111/j.1574-6968.1995.tb07353.x
- Chemother. J. v.5 Veranderungdes Erregerspsktrums beischweren nosokomailen Infektionen Lemmen, R.;F. Daschner
- Current infectious disease drugs. Aminoglycosides Lerner, S.A.;V.T. Andriole(ed.)
- Approved Standard M7-A3. national Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. National Committee for Clinical laboratory Standards
- N. Engl. J. Med. v.323 Rapid dissemination of beta-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patoents and staff on an infant-toddler surgical ward Rhinenhart, E.;N.E. Smith;C. Wennersten;E. Gorss;J. Freeman;G.M. Eliopoulos;R.C. Moellering,Jr;D.A. Goldman https://doi.org/10.1056/NEJM199012273232606
- Am. J. Med. v.91 Major trends in the microbial etiology of nosocomial infection Schaberg, D.R.;D.H. Culver;R.P. Gaynes
- Eur. J. Clin. Microbiol. Infect. Dis. v.9 Enterococcal resistance to vancomycin and related cyclic glycopeptide antibiotics Shales, D.M.;B. Binczeroski https://doi.org/10.1007/BF01963634
- J. Clin. Microbiol. v.36 Characterization of Staphylococci with reduced susceptibility to vancomycin and other glycopeptides Ternover, F.C.;M.V. Lancaster;B.C. Hill;C.D. Steward;S.A. Stocker;G.A. Hancock;C.M. O'Hara;N.C. Clark;K. Hiramatsu
- Vancomycin-resistant enterococci. Lancet v.335 Uttley, A.H.C.;C.H. Collins;J. Naidoo;R.C. George
- J. Infect. Dis. v.173 Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly-resistant enterococci van der Auwera, P.;N. Pensart;V. Korten;B.E. Murray;R. Leclerq https://doi.org/10.1093/infdis/173.5.1129